Oscar Ardenfors

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: EJNMMI RESEARCH. 2024;14(1):13
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy
Persson M; Hindorf C; Ardenfors O; Larsson M; Nilsson JN
Article: EJNMMI RESEARCH. 2023;13(1):73
Comparative in vivo biodistribution of cells labelled with [⁸⁹Zr]Zr-(oxinate)₄ or [⁸⁹Zr]Zr-DFO-NCS using PET
Friberger I; Nilsson JNN; Lu L; Siikanen J; Ardenfors O; Milton S; Samen E; Goos JACM; Carlsten M; Holmin S; Tran TAA
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2022;99:68-72
Dosimetric dependencies on target geometry and size in radioiodine therapy for differentiated thyroid cancer
Nilsson JN; Siikanen J; Lundgren CI; Ardenfors O
Article: EJNMMI PHYSICS. 2022;9(1):44
Simplified dosimetry for kidneys and tumors in ¹⁷⁷Lu-labeled peptide receptor radionuclide therapy
Ardenfors O; Nilsson JN; Thor D; Hindorf C
Article: THYROID RESEARCH. 2022;15(1):8
Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism
Nilsson JN; Elovsson R; Thor D; Calissendorff J; Ardenfors O
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2020;76:1-6
Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties
Raptis A; Oden J; Ardenfors O; Flejmer AM; Toma-Dasu I; Dasu A
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2018;53:56-61
Organ doses from a proton gantry-mounted cone-beam computed tomography system characterized with MCNP6 and GATE
Ardenfors O; Henry T; Gudowska I; Poludniowski G; Dasu A
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2018;53:129-136
Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment.
Ardenfors O; Dasu A; Lillhök J; Persson L; Gudowska I
Article: EJNMMI RESEARCH. 2015;5(1):48
Reduced acquisition times in whole body bone scintigraphy using a noise-reducing Pixon®-algorithm-a qualitative evaluation study
Ardenfors O; Svanholm U; Jacobsson H; Sandqvist P; Gryback P; Jonsson C
Article: RADIATION PROTECTION DOSIMETRY. 2014;161(1-4):357-362
RADIATION BURDEN FROM SECONDARY DOSES TO PATIENTS UNDERGOING RADIATION THERAPY WITH PHOTONS AND LIGHT IONS AND RADIATION DOSES FROM IMAGING MODALITIES
Gudowska I; Ardenfors O; Toma-Dasu I; Dasu A

Alla övriga publikationer

Published conference paper: RADIATION PROTECTION DOSIMETRY. 2018;180(1-4):296-299
MONTE CARLO SIMULATIONS OF SPATIAL LET DISTRIBUTIONS IN CLINICAL PROTON BEAMS.
Grzanka L; Ardenfors O; Bassler N
Published conference paper: RADIATION PROTECTION DOSIMETRY. 2018;180(1-4):338-341
RADIATION PROTECTION MEASUREMENTS WITH THE VARIANCE-COVARIANCE METHOD IN THE STRAY RADIATION FIELDS FROM PHOTON AND PROTON THERAPY FACILITIES.
Lillhök J; Persson L; Andersen CE; Dasu A; Ardenfors O
Published conference paper: RADIATION PROTECTION DOSIMETRY. 2018;180(1-4):261-266
Impact of irradiation setup in proton spot scanning brain therapy on organ doses from secondary radiation.
Ardenfors O; Gudowska I; Flejmer AM; Dasu A
Published conference paper: ACTA ONCOLOGICA. 2014;53(8):1041-1047
Are IMRT treatments in the head and neck region increasing the risk of secondary cancers?
Ardenfors O; Josefsson D; Dasu A

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI